NDC 72162-1741-01 - Ciprofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1741
- Requested NDC
- 72162-1741-01
- Package NDCs from labels
- 72162-1741-1, 72162-1741-2, 72162-1741-3, 72162-1741-4, 72162-1741-5, 72162-1741-6, 72162-1741-7, 72162-1741-8, 72162-1741-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2025-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ciprofloxacin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1741-1 | Ciprofloxacin | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 106 | |
| 72162-1741-2 | Ciprofloxacin | 14 in 1 BOTTLE | TABLET, FILM COATED | 14 | 106 | |
| 72162-1741-3 | Ciprofloxacin | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 106 | |
| 72162-1741-4 | Ciprofloxacin | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 106 | |
| 72162-1741-5 | Ciprofloxacin | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 106 | |
| 72162-1741-6 | Ciprofloxacin | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 106 | |
| 72162-1741-7 | Ciprofloxacin | 10 in 1 BOTTLE | TABLET, FILM COATED | 10 | 106 | |
| 72162-1741-8 | Ciprofloxacin | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | 106 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1741 | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) TABLET, FILM COATED [BRYANT RANCH PREPACK] | 106 | Current NDC, 8 package rows | 20250403_99918613-7936-47dd-8565-9cd6c0cc22e3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1741-1 | EA - Each | 72162-1741 | 723464b2-4c64-4a2e-99c6-b29fd3b42ff3 | 1 | 2024-03-12 |
| 72162-1741-2 | EA - Each | 72162-1741 | 739bc4c5-9bc4-416f-aeef-4d9437a43003 | 1 | 2023-12-05 |
| 72162-1741-3 | EA - Each | 72162-1741 | 190c9985-2836-48d1-9455-e1a8b1c082a8 | 1 | 2023-12-05 |
| 72162-1741-4 | EA - Each | 72162-1741 | 8b602fdd-38de-48a7-b98c-acc6718e583e | 1 | 2023-10-16 |
| 72162-1741-5 | EA - Each | 72162-1741 | eb832750-2dc2-499a-b86c-cc7f852bb0f5 | 1 | 2024-01-04 |
| 72162-1741-6 | EA - Each | 72162-1741 | ea96cb82-9bfb-4348-985b-d81042f7c88c | 1 | 2023-10-16 |
| 72162-1741-7 | EA - Each | 72162-1741 | 4a735290-2388-4f42-9c18-a27811b4de6a | 1 | 2023-10-16 |
| 72162-1741-8 | EA - Each | 72162-1741 | 3bc9732d-c81f-44d6-8b05-e72aee62b2d4 | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ciprofloxacin | CIPROFLOXACIN | Northwind Health Company, LLC | f6debb60-d885-230b-e053-6394a90ad73a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 309309 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN | Northwind Health Company, LLC | f67d727f-b9ca-aec0-e053-2995a90aab69 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 197511 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN TABLETS | Yiling Pharmaceutical, Inc. | 6fd3da0b-7428-ac8f-e053-2a91aa0aed9f | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 309309 197511 4BA73M5E37 |
| Ciprofloxacin and dexamethasone | CIPROFLOXACIN AND DEXAMETHASONE | Redpharm Drug | 2fd20fcb-222c-bd38-e063-6294a90ac9cd | 2025-12-27 | Warnings, Adverse reactions | 4BA73M5E37 |
| Ciprofloxacin | CIPROFOLXACIN | Redpharm Drug | 3253a41f-4f0a-5d83-e063-6294a90a890c | 2025-12-24 | Boxed warning, Warnings, Adverse reactions | 309309 4BA73M5E37 |
| Ciprofloxacin | CIPROFOLXACIN | NuCare Pharmaceutical, Inc. | 24760182-4be8-9f43-e063-6294a90a269e | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 197511 4BA73M5E37 |
| Ciprofloxacin | CIPROFOLXACIN | Redpharm Drug | 3b0af0f2-1d33-1ffe-e063-6394a90aca7c | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 197511 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN | QPharma Inc | 4d5afeff-3917-43e1-9d12-d70ccab00dcc | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 309309 4BA73M5E37 |
| Ciprofloxacin | CIPROFOLXACIN | NuCare Pharmaceuticals,Inc. | 1b189dba-0493-c9b4-e063-6294a90a7d1e | 2025-12-03 | Boxed warning, Warnings, Adverse reactions | 309309 4BA73M5E37 |
| ciprofloxacin hydrochloride and hydrocortisone | CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | Cosette Pharmaceuticals, Inc. | 6848cb55-7ca4-40ca-9751-f1fc262b8336 | 2025-12-01 | Warnings, Adverse reactions | 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 74e2dd24-5c6e-4dde-a2ab-f2d2e61734d8 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | ANDA076126 309309 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | cfda82e4-8660-447e-a881-b87165a31e9a | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | ANDA076126 309309 4BA73M5E37 |
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | REMEDYREPACK INC. | a2cec2cc-729b-4baa-8df1-c3f70847a483 | 2025-11-05 | Warnings, Adverse reactions | 4BA73M5E37 |
| Ciprofloxacin Hydrochloride | CIPROFLOXACIN HYDROCHLORIDE | VERITYRX, LLC | 42542f65-84a7-fdab-e063-6394a90a1095 | 2025-11-03 | Boxed warning, Warnings, Adverse reactions | 309309 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 1dca6149-00ca-480e-a887-6861e40803b9 | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | ANDA076126 197511 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN | Method Pharmaceuticals, LLC | acb03e72-ce94-58c5-e053-2a95a90a683a | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | 309309 197511 4BA73M5E37 |
| ciprofloxacin | CIPROFLOXACIN | QPharma, Inc. | 4149d980-a6cd-c06d-e063-6394a90a47a1 | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 309309 4BA73M5E37 |
| Ciprofloxacin | CIPROFOLXACIN | NuCare Pharmaceuticals,Inc. | 41206a0f-7a5b-6a12-e063-6394a90a58b1 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 197511 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | Chartwell RX, LLC. | 6c64aa79-d087-4568-904c-3a0638b91e69 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | 309309 197511 197512 4BA73M5E37 |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | A-S Medication Solutions | 6e37322b-89d3-4b66-8e1b-c4ad79eed173 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | ANDA076126 197511 4BA73M5E37 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.